Aiman al-Mudaifer was appointed acting chief executive in November following the abrupt departure of Nadhmi al-Nasr, who led the $500bn mega project for six years but faced increasing scrutiny over ...

The “deathcare” giant’s executive continued to take the sky with aplomb in 2024 — albeit slightly less than the year before. Thomas L. Ryan, its chair and chief executive, notched up $241,785 in ...